Author

Ivanna L. Rocha

University of Florida Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Lyle L. MoldaweriD· 2 shared Philip Alexander EfroniD· 2 shared Ricardo F. Ungaro· 2 shared Tyler John LoftusiD· 2 shared Alicia M. MohriD· 1 shared Andrew H. WaltoniD· 1 shared Angel M. CharlesiD· 1 shared Anne M. DrewryiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Lyle L. MoldawerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Divergent chromatin remodeling in post-sepsis MDSCs underlies MHC class II repression in CCI

Jason Orr Brant, Marie‐Pierre L. Gauthier, Christine E. Rodhouse, Ruoxuan Wu, Miguel Hernández-Ríos, Leilani Zeumer-Spataro, Marvin L. S. Dirain, Ricardo F. Ungaro, Ivanna L. Rocha, Whittman B. Wiggins, Angel M. Charles, Feifei Xiao, Letitia E. Bible, Alicia M. Mohr, Shawn D. Larson, , Michael P. Kladde

The paper profiles chromatin accessibility in post-sepsis MDSCs, showing divergent epigenetic trajectories between rapid recovery and chronic critical illness, with MHC class II repression in CCI.

bioRxiv · Jul 2, 2026 · PreprintImmunology

Determining potential immunomodulatory drug efficacy in sepsis using ELISpot

Andrew H. Walton, Monty B. Mazer, Kenneth E. Remy, Dale F. Osborne, Ethan Davitt, Thomas S. Griffith, Robert W. Gould, Vladimir P. Badovinac, Scott C. Brakenridge, Anne M. Drewry, Ricardo F. Ungaro, Ivanna L. Rocha, Tyler John Loftus, Philip Alexander Efron, Lyle L. Moldawer, , Richard S. Hotchkiss

This study uses ELISpot to assess immunomodulatory drug effects on cytokine production in sepsis patients and healthy controls.

Scientific Reports · Apr 18, 2025Peer-reviewedImmunology